KNSA - Kiniksa Pharmaceuticals Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

KNSA is currently covered by 8 analysts with an average price target of $82.18. This is a potential downside of $11.72 (-12.48%) from yesterday's end of day stock price of $93.9.

Kiniksa Pharmaceuticals Ltd's activity chart (see below) currently has 97 price targets and 89 ratings on display. The stock rating distribution of KNSA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 94.31% of the time, taking 620.5 days on average.

Highest price target for KNSA is $107, Lowest price target is $57, average price target is $82.18.

Most recent stock forecast was given by PAUL CHOI from GOLDMAN SACHS on 28-Oct-2026. First documented stock forecast 18-Jun-2018.

Best performing analysts who are covering KNSA - Kiniksa Pharmaceuticals Ltd:

Roger Song Edward Nash Geoff Meacham Anupam Rama Liisa Bayko Paul Choi

Currently out of the existing stock ratings of KNSA, 26 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Jun-2020

$101

$7.1 (7.56%)

$90

24 days ago
(28-Oct-2026)

14/15 (93.33%)

$5.82 (6.11%)

866

Buy Since 18-Jun-2018

$102

$8.1 (8.63%)

$99

24 days ago
(28-Oct-2026)

19/21 (90.48%)

$6.82 (7.17%)

658

Buy Since 11-Mar-2019

$100

$6.1 (6.50%)

$60

3 months 23 days ago
(29-Jul-2026)

9/10 (90%)

$19.08 (23.58%)

796

Buy Since 18-Jun-2018

$107

$13.1 (13.95%)

$55

3 months 23 days ago
(29-Jul-2026)

12/13 (92.31%)

$26.08 (32.23%)

597

Buy Since 18-Feb-2026

$98

$4.1 (4.37%)

$64

3 months 23 days ago
(29-Jul-2026)

3/3 (100%)

$17.08 (21.11%)

99

Show more analysts

Please expand the browser size to see the chart

What is KNSA (Kiniksa Pharmaceuticals Ltd) average time for price targets to be met?

On average it took 621 days for the stock forecasts to be reached, with an average price target met ratio of 94.31%.

Which analyst most recently updated their price target on KNSA (Kiniksa Pharmaceuticals Ltd)?

Paul Choi

Which analyst has the most public recommendations on KNSA (Kiniksa Pharmaceuticals Ltd)?

Paul Choi works at GOLDMAN SACHS and has 3 price targets and 2 ratings on KNSA

Which analyst is the currently most bullish on KNSA (Kiniksa Pharmaceuticals Ltd)?

Anupam Rama with the highest potential upside of $13.1

Which analyst is the currently most reserved on KNSA (Kiniksa Pharmaceuticals Ltd)?

Liisa Bayko with the lowest potential downside of -$58.9
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?